BioRestorative Graham Number from 2010 to 2025

BRTX Stock  USD 1.97  0.06  2.96%   
BioRestorative Therapies Graham Number yearly trend continues to be fairly stable with very little volatility. Graham Number will likely drop to 12.54 in 2025. During the period from 2010 to 2025, BioRestorative Therapies Graham Number regression line of annual values had r-squared of  0.50 and arithmetic mean of  36,354. View All Fundamentals
 
Graham Number  
First Reported
2010-12-31
Previous Quarter
13.2
Current Value
12.54
Quarterly Volatility
50.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BioRestorative Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioRestorative Therapies' main balance sheet or income statement drivers, such as Interest Expense of 12.7 K, Selling General Administrative of 7.7 M or Depreciation And Amortization of 178.1 K, as well as many indicators such as Price To Sales Ratio of 54.99, Dividend Yield of 0.0 or PTB Ratio of 0.69. BioRestorative financial statements analysis is a perfect complement when working with BioRestorative Therapies Valuation or Volatility modules.
  
Check out the analysis of BioRestorative Therapies Correlation against competitors.
For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.

Latest BioRestorative Therapies' Graham Number Growth Pattern

Below is the plot of the Graham Number of BioRestorative Therapies over the last few years. It is BioRestorative Therapies' Graham Number historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioRestorative Therapies' overall financial position and show how it may be relating to other accounts over time.
Graham Number10 Years Trend
Slightly volatile
   Graham Number   
       Timeline  

BioRestorative Graham Number Regression Statistics

Arithmetic Mean36,354
Geometric Mean2,347
Coefficient Of Variation139.27
Mean Deviation39,644
Median16,826
Standard Deviation50,630
Sample Variance2.6B
Range147.8K
R-Value(0.71)
Mean Square Error1.4B
R-Squared0.50
Significance0
Slope(7,500)
Total Sum of Squares38.5B

BioRestorative Graham Number History

2025 12.54
2024 13.2
2023 11.48
2022 22.14
2021 101.55
2020 48.54
201912.9 K

About BioRestorative Therapies Financial Statements

BioRestorative Therapies investors use historical fundamental indicators, such as BioRestorative Therapies' Graham Number, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioRestorative Therapies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Graham Number 13.20  12.54 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioRestorative Stock Analysis

When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.